BeyondSpring is trading 7.77% down at $0.90, with no new company announcement, filing, earnings release, or analyst action found to explain the decline.
- The stock fell from the August 5 close of $0.98.
- Available coverage lists older June updates as the latest company news.
- The broader biotech sector is higher and major indexes are mixed, offering no clear market explanation for the selling pressure.